Dr. Ryan Beal, Founder and CEO of Dyve Biosciences, joins us to discuss an innovative approach to cancer treatment using transdermal drug delivery to target tumor acidity and support the immune system’s ability to fight cancer.
With a background in medicine, pharmaceutical innovation, and entrepreneurship, Ryan shares insights into the science behind this technology and the future of oncology.
#MedTech #Biotech #CancerResearch #HealthcareInnovation
RSS Feed